Dolby Laboratories Stock Price and Value Analysis

Dolby Laboratories (NYSE:DLB) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Dolby Laboratories to reach your target.

Target type

DLB Free Cash Flow Trend

Free Cash Flow trendline for DLB
Free Cash Flow trendline for Dolby Laboratories
CSV

Based on historical returns, we believe that Dolby Laboratories can grow its free cash at a rate of about 13%. That's positive!

AdvantagesDisadvantages
  • This company has stable growth.
  • This company is making money at a great rate!
  • This stock is available at a great discount!
  • This company has an average dividend yield.
  • This company is less known than others.

Inside the DLB Numbers

DLB Price
(Dolby Laboratories stock price per share)
$64.70
[?] DLB Fair Price
(based on intrinsic value)
$136.64
[?] DLB Safety Price (based on a variable margin of safety) $81.98
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 107% higher than other Financial Services stocks
[?] PE Ratio versus Industry 478% higher than other Financial Data & Stock Exchanges stocks
[?] Cash Yield 3.17%
[?] Free Cash Flow Jitter 20%
[?] Dividend Yield 2.23% (tax impact)
Shares Shorted 6,006,027

Insider Activity Summary

In the six months to 2026-11-13, no insider bought shares, and 4 insiders sold in 12 trades, about $2.9 million.

The six months before that had 0 buys and 24 sales.

Recent Insider Activity

Open-market buys and sells reported by Dolby Laboratories's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.

Date Insider Type Shares Price
2026-09-01 Couling John D (SVP, Entertainment) Sell 7,667 $61.05
2026-08-25 Nicholson Ryan (VP, CAO and Corp. Controller) Sell 1,183 $65.28
2026-08-14 Revankar Shriram (SVP, Advanced Technology Group) Sell 3,000 $62.71
2026-08-10 Nicholson Ryan (VP, CAO and Corp. Controller) Sell 1,348 $62.04
2026-08-04 Nicholson Ryan (VP, CAO and Corp. Controller) Sell 357 $60.63
2026-08-03 Couling John D (SVP, Entertainment) Sell 6,884 $60.11
2026-08-03 Couling John D (SVP, Entertainment) Sell 783 $59.03
2026-07-01 Couling John D (SVP, Entertainment) Sell 7,667 $53.20
2026-06-01 Couling John D (SVP, Entertainment) Sell 508 $56.16
2026-06-01 Couling John D (SVP, Entertainment) Sell 7,158 $55.59

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 6,006,027 shares shorted. With 58,759,372 shares available for purchase and an average trading volume over the past 10 trading days of 626,930, it would take at least 9.6 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2008 1308547 250.9
2009 1308547 259.4
2010 1308547 305.6
2011 1308547 375.6
2012 1308547 334.0
2013 1308547 217.9
2014 1308547 290.7
2015 1308547 214.5
2016 1308547 254.5
2017 1308547 285.8
2018 1308547 251.0
2019 1308547 222.3
2020 1308547 256.7
2021 1308547 369.9
2022 1308547 251.0
2023 1308547 308.0
2024 1308547 281.4
2025 1308547 432.4

Download the yearly data as CSV.

Price Versus Our Estimated Value

Dolby Laboratories is priced at $64.70, under its safe value estimate of $81.98 (fair value: $136.64).

Free cash flow was positive in all 18 fiscal years we have for Dolby Laboratories under its current SEC filer.

Free cash flow from the first three years of data averaged $272.0 million, and from the last three $340.6 million: a sharp rise.

Year-to-year variability in free cash flow is fairly steady, measured at 20%.

These numbers change when new filings or prices arrive, so treat this page as a snapshot and check the company's own filings.

The dividend yield for Dolby Laboratories is 2.23%.

Compared With Its Sector and Industry

Its trailing P/E ratio is 107% above the average for stocks in the Financial Services sector.

Its trailing P/E ratio is 478% above the average for stocks in the Financial Data & Stock Exchanges industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 1308547.

Each figure on this page comes from that filer.

Risks to This Analysis

  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in DLB

Does Dolby Laboratories have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: DLB

This example shows how we apply the Trendshare checklist to DLB: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 64.70
    • Market cap: $6.1B
    • EPS: 2.35
  2. Step 2 — Valuation checks

    • P/E: 27.532
    • FCF yield: 3.2%
    • Date checked: Nov 12, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.